Bode Bruce, Gross Kenneth, Rikalo Nancy, Schwartz Sherwyn, Wahl Timothy, Page Casey, Gross Todd, Mastrototaro John
Atlanta Diabetes Associates, Atlanta, Georgia, USA.
Diabetes Technol Ther. 2004 Apr;6(2):105-13. doi: 10.1089/152091504773731285.
The purposes of this study were to demonstrate the accuracy and effectiveness of the Guardian Continuous Monitoring System (Medtronic MiniMed, Northridge, California) and to demonstrate that the application of real-time alarms to continuous monitoring alerts users to hypo and hyperglycemia and reduces excursions in people with diabetes. A total of 71 subjects with type 1 diabetes, mean hemoglobin A1c of 7.6 +/- 1.1%, age 44.0 +/- 11.4 years, and duration of diabetes 23.6 +/- 10.6 years were enrolled in this two-period, randomized, multicenter study. Subjects were randomized into either an Alert group or a Control group. The accuracy of the Guardian was evaluated by treating the study data as a single-sample correlational design. Effectiveness of the Guardian alerts was evaluated by comparing the Alert group with the Control group. The mean (median) absolute relative error between home blood glucose meter readings and sensor values was 21.3% (17.3%), and the Guardian, on average, read 12.8 mg/dL below the concurrent home blood glucose meter readings. The hypoglycemia alert was able to distinguished glucose values < or =70 mg/dL with 67% sensitivity, 90% specificity, and 47% false alerts. The hyperglycemia alert showed a similar ability to detect sensor values > or =250 mg/dL with 63% sensitivity, 97% specificity, and 19% false alerts. The Alert group demonstrated a median decrease in the duration of hypoglycemic excursions (-27.8 min) that was significantly greater than the median decrease in the duration of hypoglycemic excursions in the Control group (-4.5 min) (P = 0.03). A marginally significant increase in the frequency of hyperglycemic excursions (P = 0.07) between Period 1 and Period 2 was accompanied by a decrease of 9.6 min in the duration of hyperglycemic excursions in the Alert group. Glucose measurements differ between blood samples taken from the finger and interstitial fluid, especially when levels are changing rapidly; however, these results demonstrate that the Guardian is reasonably accurate while performing continuous glucose monitoring. The subjects' responses to hypoglycemia alerts resulted in a significant reduction in the duration of hypoglycemic excursions; however, overtreating hypoglycemia may have resulted in a marginally significant increase in the frequency of hyperglycemic excursions.
本研究的目的是证明Guardian连续监测系统(美敦力MiniMed,加利福尼亚州北岭)的准确性和有效性,并证明将实时警报应用于连续监测可提醒糖尿病患者注意低血糖和高血糖情况,并减少血糖波动。共有71名1型糖尿病患者参与了这项为期两阶段的随机多中心研究,他们的平均糖化血红蛋白为7.6±1.1%,年龄为44.0±11.4岁,糖尿病病程为23.6±10.6年。受试者被随机分为警报组或对照组。通过将研究数据视为单样本相关设计来评估Guardian的准确性。通过比较警报组和对照组来评估Guardian警报的有效性。家用血糖仪读数与传感器值之间的平均(中位数)绝对相对误差为21.3%(17.3%),Guardian平均比同期家用血糖仪读数低12.8mg/dL。低血糖警报能够以67%的灵敏度、90%的特异性和47%的误报率识别血糖值≤70mg/dL。高血糖警报显示出类似的能力,能够以63%的灵敏度、97%的特异性和19%的误报率检测传感器值≥250mg/dL。警报组的低血糖发作持续时间中位数下降(-27.8分钟),显著大于对照组的低血糖发作持续时间中位数下降(-4.5分钟)(P=0.03)。警报组在第1阶段和第2阶段之间高血糖发作频率略有显著增加(P=0.07),同时高血糖发作持续时间减少了9.6分钟。从手指采集的血样和间质液中的葡萄糖测量值有所不同,尤其是当血糖水平快速变化时;然而,这些结果表明,Guardian在进行连续血糖监测时具有合理的准确性。受试者对低血糖警报的反应导致低血糖发作持续时间显著减少;然而,过度治疗低血糖可能导致高血糖发作频率略有显著增加。